Fresenius Medical Care AG (NYSE:FMS) Short Interest Update

Fresenius Medical Care AG (NYSE:FMS) was the target of a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 730,200 shares, a growth of 6.9% from the September 30th total of 683,300 shares. Based on an average daily volume of 294,500 shares, the short-interest ratio is currently 2.5 days.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Allworth Financial LP increased its holdings in Fresenius Medical Care by 53.1% in the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock worth $36,000 after purchasing an additional 581 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Fresenius Medical Care by 50.4% in the third quarter. GAMMA Investing LLC now owns 4,998 shares of the company’s stock valued at $106,000 after buying an additional 1,675 shares during the period. ORG Wealth Partners LLC acquired a new stake in Fresenius Medical Care during the 3rd quarter worth approximately $112,000. ORG Partners LLC bought a new stake in Fresenius Medical Care during the 1st quarter worth approximately $110,000. Finally, SageView Advisory Group LLC acquired a new position in Fresenius Medical Care in the 1st quarter valued at approximately $127,000. 8.25% of the stock is currently owned by institutional investors.

Fresenius Medical Care Price Performance

Fresenius Medical Care stock traded up $0.26 during midday trading on Friday, reaching $19.80. The company’s stock had a trading volume of 322,946 shares, compared to its average volume of 370,359. The stock has a market cap of $11.62 billion, a PE ratio of 20.14, a price-to-earnings-growth ratio of 0.93 and a beta of 0.91. The company has a current ratio of 1.46, a quick ratio of 1.09 and a debt-to-equity ratio of 0.45. Fresenius Medical Care has a 52 week low of $16.66 and a 52 week high of $22.76. The business has a 50-day moving average price of $20.32 and a 200-day moving average price of $20.17.

Fresenius Medical Care (NYSE:FMS) last released its quarterly earnings data on Tuesday, July 30th. The company reported $0.38 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.38. Fresenius Medical Care had a net margin of 2.72% and a return on equity of 5.48%. The business had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.28 billion. On average, sell-side analysts predict that Fresenius Medical Care will post 1.52 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. StockNews.com started coverage on shares of Fresenius Medical Care in a research report on Friday. They issued a “strong-buy” rating on the stock. Truist Financial upped their price target on shares of Fresenius Medical Care from $22.00 to $23.00 and gave the stock a “hold” rating in a report on Monday, October 7th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Fresenius Medical Care has a consensus rating of “Hold” and an average target price of $23.00.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.